Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
4162587 | Journal of Pediatric Urology | 2012 | 4 Pages |
Abstract
Endoscopic management of vesicoureteral reflux with dextranomer/hyaluronic copolymer (Deflux®, Oceana Therapeutics, Inc., Edison, NJ, USA) has gained widespread acceptance with increasing success rates and minimal morbidity. Formation of a pseudocapsule and calcification are known histologic changes at the injection site. Postoperative ureteral obstruction has been reported in cases of severe voiding dysfunction, neurogenic bladder and abnormal ureteral anatomy. We present a case of chronic asymptomatic obstruction in a normal ureter following injection of 0.7 ml Deflux.
Related Topics
Health Sciences
Medicine and Dentistry
Perinatology, Pediatrics and Child Health
Authors
Angela M. Arlen, Brittany L. Pakalniskis, Christopher S. Cooper,